ESPR — ESPERION THERAPEUTICS INC NE

Ownership history in Two Seas Capital LP  ·  11 quarters on record

This page tracks every 13F SEC filing in which Two Seas Capital LP reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.61% (2023 Q4)
Avg. % of fund
1.55%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 11,902,521 +2,152,797 +22.1% 0.91% $44.0M $3.70
2025 Q3 REDUCED 9,749,724 -205,251 -2.1% 0.41% $25.8M $2.65
2025 Q2 ADDED 9,954,975 +3,024,104 +43.6% 0.16% $9.8M $0.98
2025 Q1 ADDED 6,930,871 +700,000 +11.2% 0.31% $10.0M $1.44
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ESPR price (monthly, adj. close)

Other funds also holding ESPR

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 3.58% Velan Capital Investment Management LP 3Y 2.6% PenderFund Capital Management Ltd. 3Y 7Y 2.56% Eversept Partners, LP 3Y 7Y 0.72% nVerses Capital, LLC 0.56% ORBIMED ADVISORS LLC 3Y 7Y 0.45% Summit Wealth Group, LLC 3Y 0.29% WASATCH ADVISORS LP 3Y 7Y 0.21% Virtus Investment Advisers, LLC 3Y 7Y 0.18% Diametric Capital, LP 3Y 7Y 0.17%
← Back to Two Seas Capital LP Holdings